Zoetis.com uses cookies to improve your experience when browsing our website. By continuing to use this site, you are agreeing to their use. To find out more, view our cookie policy.


Gregory Norden

Gregory Norden

Gregory Norden has served as a member of our board since January 2013. He is the Managing Director of G9 Capital Group LLC, which invests in early stage ventures and provides corporate finance advisory services. From 1989 to 2010, Mr. Norden held various senior positions with Wyeth/American Home Products, most recently as Wyeth’s Senior Vice President and Chief Financial Officer. Prior to this role, Mr. Norden was Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals. Prior to his affiliation with Wyeth, Mr. Norden served as Audit Manager at Arthur Andersen & Co. Mr. Norden also serves on the Board of Directors of NanoString Technologies, a provider of life science tools for translational research and development of molecular diagnostic products, Royalty Pharma, a leader in the acquisition of revenue-producing intellectual property, and Univision, the leading media company serving Hispanic America.  Mr. Norden is a former director of Welch Allyn, where he served until 2015, Lumara Health, where he served until 2014, and Human Genome Sciences, where he served until 2012.

About Us

See Zoetis at a glance.